Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOn the Wegovy 1mg pen, one full weekly dose requires four clicks — each click delivers 0.25mg of semaglutide, so pressing the button four times completes the 1mg injection. That four-click total is the same physical action each week until your prescriber moves you to the next step on the titration ladder. Because Wegovy is a prescription-only medicine, the schedule you follow is set by a clinician, not chosen by you, and the Patient Information Leaflet in your box is always the definitive reference for your specific device.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The phrase "click chart" has become shorthand for a straightforward reference table: Wegovy dose on one side, number of button presses on the other. At the 1mg step, you are pressing the injection button four times in a single session, pausing between each click until you hear and feel it register before moving to the next. The pen itself is pre-filled; there is nothing to draw up or measure.
It helps to understand why the clicks work this way. Each Wegovy pen is calibrated so that one button depression releases 0.25mg. The device does not have a continuous plunger, the mechanism steps in fixed increments. That design means the click chart for the 1mg dose is simply: four presses, four increments of 0.25mg, one completed injection. The math is the same whether you are injecting into your abdomen, thigh, or upper arm, and the injection site does not change the number of clicks required.
For people who have recently stepped up from 0.5mg, the pen format may actually be identical; the instruction changes, not the hardware. The 0.5mg click chart covers the previous step in detail if you want to compare the two. One practical note: the pen arrives in plain, unmarked packaging, a DPD tracking notification on your phone lets you know it is on its way, so you are not waiting on a delivery that comes without warning.
The NHS medicines information for semaglutide confirms the step-wise titration design and the once-weekly injection schedule. Always read the leaflet that comes with your specific batch, since device generations can differ slightly in their labelling.
Most people searching for a 1mg wegovy click chart are facing one of two situations: they are about to give their first 1mg injection and want to feel confident they have done it correctly, or they have a nagging doubt about whether they completed their last dose and are deciding what to do next.
Both are reasonable and common. A question our prescribers hear regularly is: "I only counted three clicks, did I get the full dose?" If that happens, the guidance is consistent: do not attempt a partial make-up dose. Contact your prescriber or pharmacist, explain what occurred, and follow their advice on whether to proceed as normal the following week or take any other step. The semaglutide dosing schedule is managed over months, and a single uncertain injection is not cause for alarm, but it is worth a conversation rather than a guess.
If you are weighing up where you are in the titration pathway more broadly, the full Wegovy dose guide sets out each stage and what each step is intended to achieve clinically. Understanding the purpose of the 1mg level (building tolerance before the more therapeutic 1.7mg and 2.4mg doses) makes the schedule feel less arbitrary.
There is also a related decision some people sit with at this stage: whether private treatment is the right route for them. The cost of Wegovy in the UK covers what private prescriptions realistically involve, which is worth reading before or alongside any consultation.
Moving to 1mg from 0.5mg typically happens after four weeks, provided the lower dose has been tolerated. The side-effect picture at 1mg is broadly similar to earlier steps, nausea, changes in appetite, and sometimes fatigue are most common in the days following an injection, often settling as the body adjusts. The January 2026 MHRA Drug Safety Update noted acute pancreatitis as a known, infrequent but serious possibility with GLP-1 medicines: severe stomach pain that reaches toward the back and does not ease warrants prompt medical attention, at any dose level.
At 1mg, many people begin to notice more meaningful appetite change than at 0.5mg, though individual responses vary considerably. Weight change at this stage is not the final picture, the licensed maintenance doses of 1.7mg and 2.4mg (and now the 7.2mg dose approved by the MHRA in April 2026) are where the longer-term evidence is strongest.
The 1.7mg click chart covers the next step up, including the corresponding click count, if you want to know what lies ahead. For those looking back, the 0.25mg click chart documents the very first starter step.
Wegovy is a prescription-only medicine. A prescriber assesses whether moving up the schedule is clinically appropriate, it is not automatic. If you are not yet on treatment and are exploring how the titration works, the full picture of the medicine is covered in the Wegovy overview. For those ready to start a clinical assessment, our prescribers at weight-loss treatments review consultations the same day, personally. The NHS semaglutide medicines page provides the patient-level reference for how the drug is used and what to report.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.